Replies to post #235736 on Biotech Values

[jbog]

I believe the 42% is taking in account the exercise of all outstanding options whereas the 54% is the current outstanding.

Aptevo Therapeutics (NASDAQ:APVO) rose 113% premarket, currently trading at $50.52 after Tang Capital Partners reported a 54.4% stake in a new 13D regulatory filing.

[TheFinalCD]

$HRTX $19.00 Tang Capital takes 9.99% 13D stake https://fintel.io/i/tang-capital-partners-lp